You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Contributors include Luc Berlivet (INSERM, CNRS, EHESS, Paris), Alberto Cambrosio (McGill University), Sir Iain Chalmers (James Lind Library, Oxford), Nicholas Dodier (INSERM, CNRS, EHESS, Paris), Michael Donnelly (Bard College), Volker Hess (Humboldt-University), Peter Keating (University of Quebec at Montreal), Ann La Berge (Virginia Tech University), Ilana Löwy (INSERM, CNRS, EHESS, Paris), Harry M. Marks (Johns Hopkins University), Lion Murard (INSERM, CNRS, Paris), Mark Parascandola (National Cancer Institute, Bethesda, Maryland), Theodore M. Porter (University of California at Los Angeles), Andrea Rusnock (University of Rhode Island), Christiane Sinding (INSERM, CNRS, EHESS, Paris), and Ulrich Tröhler (Institut für Geschichte der Medizin der Albert-Ludwigs-Universität).
First multi-year cumulation covers six years: 1965-70.
An examination of postwar medicine based on the notion of the biomedical platform--the theoretical and clinical meeting ground between the normal and the pathological.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
Twenty years ago when Children's Cancer Association of Japan was born, the diagnosis of childhood leukemia amounted to a death sentence. Only 20% or so of children with leukemia survived more than 5 years. Since then, enormous improvements have been achieved regarding our understanding on the etiology, diagnosis, and the treatment of childhood leukemia. Now, 70% of children with leukemia survive and enter adult life. Even though the improved survival rate of children with leukemia represents a medical success story, we now face new problems. The first problem is the fact that we still lose 20-30% of patients with childhood leukemia. To address this problem, we need to understand the etiology...
Immune Recognition is a modified compilation of an experimental leukocyte culture conference about various aspects of macrophage and lymphocyte biology in relation to the eponymous central theme. The book is divided into nine sections. Section I covers non-antigenic signals and receptors for lymphocyte activation; the recognition of chemically modified autologous cells; surface membrane saccharides; and B and T cell activation. Section II is about antigenic signals; the activation of macrophages; and the induction of autosensitization of initiator lymphocytes. Sections III and IV discuss the early membrane and biochemical events in lymphocyte activation. Sections V to IX cover the coupling of cytoplasmic and nuclear events to membrane cycles; cellular and molecular basis of cell recognition and interaction in nonlymphocyte systems; the genetic control of immunocompetent cell interactions; and cellular mechanisms that regulate the immune response. The text is intended for doctors who specialize in immunology and want to know more about the different factors that cause the recognition of the immune system.
Building an expert system involves eliciting, analyzing, and interpreting the knowledge that a human expert uses when solving problems. Expe rience has shown that this process of "knowledge acquisition" is both difficult and time consuming and is often a major bottleneck in the production of expert systems. Unfortunately, an adequate theoretical basis for knowledge acquisition has not yet been established. This re quires a classification of knowledge domains and problem-solving tasks and an improved understanding of the relationship between knowledge structures in human and machine. In the meantime, expert system builders need access to information about the techniques currently being employ...